Idenix Pharmaceuticals Inc Sample Contracts

Exhibit 10.5 March 18, 2002 CONFIDENTIAL Mr. John Dunphy 24 Marion Lane Scotch Plains, New Jersey 07076 Dear Mr. Dunphy: On behalf of Novirio Pharmaceuticals, Inc. ("Novirio"), I am pleased to offer you the position of Chief Financial Officer. In this...
Employment Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD

On behalf of Novirio Pharmaceuticals, Inc. ("Novirio"), I am pleased to offer you the position of Chief Financial Officer. In this position, you will report directly to Novirio's Chief Executive Officer. The terms of employment set forth below are intended to reflect our prior discussions.

AutoNDA by SimpleDocs
EXHIBIT 1.1 FORM OF UNDERWRITING AGREEMENT IDENIX PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENT
Underwriting Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
W I T N E S S E T H
Lease • April 12th, 2002 • Novirio Pharmaceuticals LTD
WITNESSETH:
Settlement Agreement • June 1st, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.7 CONSULTING AGREEMENT
Consulting Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • Massachusetts
IDENIX PHARMACEUTICALS, INC. 22,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • August 3rd, 2012 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
BY AND AMONG
Stock Purchase Agreement • March 17th, 2005 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALS --------
Settlement Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
FROM
Lease Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
April 24, 2001
Stockholders' Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • New York
INTRODUCTION
License Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
RECITALS
Consulting Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • New York
BETWEEN
License Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
RECITALS:
Master Services Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
AGREEMENT
Collaboration Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
BETWEEN
License Agreement • December 15th, 2003 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 10.30 CONCURRENT PRIVATE PLACEMENT STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • June 1st, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
PAR VALUE
Stock Purchase Agreement • June 1st, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER among IDENIX PHARMACEUTICALS, INC., MERCK & CO., INC. and IMPERIAL BLUE CORPORATION Dated as of June 8, 2014
Merger Agreement • June 9th, 2014 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

AGREEMENT AND PLAN OF MERGER (hereinafter called this “Agreement”), dated as of June 8, 2014, by and among Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Merck & Co., Inc., a New Jersey corporation (“Parent”), and Imperial Blue Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub,” with the Company and Merger Sub sometimes being hereinafter collectively referred to as the “Constituent Corporations”).

BETWEEN
Cooperative Agreement • July 6th, 2004 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
RECITALS
Stock Restriction Agreement • April 12th, 2002 • Novirio Pharmaceuticals LTD • Massachusetts
IDENIX PHARMACEUTICALS, INC. 9,393,416 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • November 16th, 2011 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York

The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by J.P. Morgan Securities LLC (the “Underwriter”), of common stock, $0.001 par value, of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.

IDENIX PHARMACEUTICALS, INC. (a Delaware corporation) 6,460,672 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • April 30th, 2010 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York

Thomas Weisel Partners LLC as representative of the Underwriters named in Schedule A hereto, c/o Thomas Weisel Partners LLC One Montgomery Street, Suite 3700 San Francisco, CA 94104

RECITALS:
Lease • August 8th, 2006 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
WITNESSETH:
Packaging Agreement • August 8th, 2006 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!